---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-065680"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T07:40:17.789624+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q1 revenue up 6%, gross margin expands to 37.2%, net loss narrows

## Summary
- Net revenue $29.8M (+6% YoY); recurring Tablo consumables & services $22.7M (+20% YoY).
- Gross margin 37.2% (non-GAAP 37.6%), up from 29.2% in Q1 2024; product margin 48.3%.
- Net loss $25.8M (-$3.66/share) vs. $39.9M (-$11.77) a year ago; operating cash use down 44%.
- Reiterated FY2025 guidance: revenue $115M-$125M, non-GAAP gross margin high-30% range, cash use < $50M.
- Tariff exemption confirmed under USMCA and for chronically disabled; no expected impact.

## SEC filing metadata
- accession: 0000950170-25-065680
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017025065680/0000950170-25-065680-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017025065680/om-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-065680
- JSON: https://secwatch.observer/filing/0000950170-25-065680.json
- Plain text: https://secwatch.observer/filing/0000950170-25-065680.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.